SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: JanyBlueEyes who wrote (1031)2/15/1998 5:51:00 PM
From: tnk  Read Replies (2) | Respond to of 5736
 
any well trained nurse can already spot bilirubin, as to your savage procedure argument spend 1/2 hour walking in an icu and you'll see many many savage procedures which if hospitals were inclined or able to spend unlimited amounts of money on could be mitigated. cost/benefits analysis will never allow enough hospitals to use ccsi's product to justify the current market cap. taken a look at columbia's earnings lately?ccsi with a 175 million market cap,no sales, losing money,insiders bailing, this is a dog carrying around a short squeeze bone in its mouth and when it drops it alot of innocent investors will get hurt



To: JanyBlueEyes who wrote (1031)2/15/1998 6:58:00 PM
From: Ron Harvey  Respond to of 5736
 
Some weeks ago I was in a hospital for a lab test and overheard two pediatric nurses lamenting about the problems with taking blood from infants for constant bilirubin testing. They were both intrigued by the Chromatics device, neither having heard of it. At her request, I later phoned one of the nurses with CCSI's phone number. I should think that pediatric nurses around the world will be a potent lobbying force for CCSI's device.